Finding ROI from AI in the Mundane

About this episode

Dennis Salotti discusses the application of AI in drug companies, focusing on improving mundane tasks to enhance efficiency and trial experiences.

Dennis Salotti, executive director and head of clinical outsourcing and innovation at Jazz Pharmaceuticals, joins Srivatsan Nagaraja to talk about what AI really looks like in day-to-inside a drug company. He explains how large language models and agentic tools can streamline contracting, budgeting, and risk management—mundane but high-impact work that speeds studies and improves trial-site experience. Salotti shares how to design narrow, high‑ROI pilots, build AI fluency, avoid “AI slop,” and turn AI into a thinking partner rather than a shortcut, stacking small wins that remove grunt work, capture lessons learned, and elevate people from doers to critical thinkers.

People in this episode

Host: Srivatsan Nagaraja

Guest: Dennis Salotti

Topics covered

• AI in drug development
• clinical outsourcing
• innovation in pharmaceuticals
• contracting
• budgeting
• risk management

Keywords

• AI
• drug company
• large language models
• clinical trials
• risk management
• contracting
• budgeting

Mentioned in this episode

Organizations: Jazz Pharmaceuticals

More episodes of Life Sciences DNA Podcast

• Lessons from Insmed’s Journey to an AI First Biotech · June 11, 2026 · 46 min
• Human Accountability in an Agentic Pharma World · May 28, 2026 · 49 min
• Making AI Transformations that Stick · May 14, 2026 · 53 min
• A Pragmatic Path to AI-Enabled Commercial Operations · March 26, 2026 · 37 min
• Reimagining Scientific Work in the Age of AI Agents · March 12, 2026 · 47 min
• Orchestrating Scientists, Data, and AI to Discover New Drugs · February 26, 2026 · 46 min